GB9906217D0 - Biological materials and methods useful in the diagnosis and treatment of diseases - Google Patents
Biological materials and methods useful in the diagnosis and treatment of diseasesInfo
- Publication number
- GB9906217D0 GB9906217D0 GBGB9906217.6A GB9906217A GB9906217D0 GB 9906217 D0 GB9906217 D0 GB 9906217D0 GB 9906217 A GB9906217 A GB 9906217A GB 9906217 D0 GB9906217 D0 GB 9906217D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- diagnosis
- diseases
- treatment
- biological materials
- methods useful
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (18)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9906217.6A GB9906217D0 (en) | 1999-03-18 | 1999-03-18 | Biological materials and methods useful in the diagnosis and treatment of diseases |
GB0113011A GB2362385B (en) | 1998-11-04 | 1999-11-01 | Non-aggregated ß-forms of prion proteins |
GB0205963A GB2371049B (en) | 1998-11-04 | 1999-11-01 | Methods of making antibodies against ß-forms of prion proteins and their uses |
GB9925804A GB2348203B (en) | 1998-11-04 | 1999-11-01 | Solube beta-forms of prion proteins, methods of preparation and use |
DE69943091T DE69943091D1 (en) | 1998-11-04 | 1999-11-02 | METHOD FOR PRODUCING THE MONOMERIC BETA FORM OF A PRION PROTEIN |
AU64807/99A AU773763B2 (en) | 1998-11-04 | 1999-11-02 | Biological materials and methods useful in the diagnosis and treatment of diseases |
AT99952693T ATE493435T1 (en) | 1998-11-04 | 1999-11-02 | METHOD FOR PRODUCING THE MONOMERIC BETA FORM OF A PRION PROTEIN |
BR9915084-0A BR9915084A (en) | 1998-11-04 | 1999-11-02 | Methods of producing a beta form of a prion protein, an antibody and a prion protein aggregate, of obtaining a non-aggregated concrete form of a prion protein and a binding agent, of detecting the presence of a non-aggregate in a biological sample. fibrillar and a prion protein, antibodies and a beta form of prion protein or its aggregate in a sample, to identify a substance, to prevent and / or treat a deprived disease, to diagnose a predisposition for the presence of a prion disease and detract from a biological sample, beta form of a prion protein, antibody, hybridoma cell, agent, non-fibrillary aggregate, uses of a binding agent, an aggregate and beta form of a prion protein, kit to diagnose a disease of primary, pharmaceutical composition and vaccine composition |
EP99952693A EP1127069B1 (en) | 1998-11-04 | 1999-11-02 | Method of making a monomeric beta-form of a prion protein |
JP2000579625A JP2002531065A (en) | 1998-11-04 | 1999-11-02 | Biological materials and methods useful in diagnosis and treatment of disease |
NZ511426A NZ511426A (en) | 1998-11-04 | 1999-11-02 | Biological materials and methods useful in the diagnosis and treatment of diseases |
CA002348751A CA2348751A1 (en) | 1998-11-04 | 1999-11-02 | Biological materials and methods useful in the diagnosis and treatment of diseases |
US09/431,887 US6534036B1 (en) | 1998-11-04 | 1999-11-02 | Biological materials and methods useful in the diagnosis and treatment of diseases |
PCT/GB1999/003617 WO2000026238A2 (en) | 1998-11-04 | 1999-11-02 | Biological materials and methods useful in the diagnosis and treatment of prion diseases |
ARP990105585A AR035004A1 (en) | 1998-11-04 | 1999-11-04 | A BETA FORM OF PRION PROTEIN, A METHOD FOR THEIR PREPARATION, A COMPOSITION THAT CONTAINS IT, USE OF THE SAME FOR THE MANUFACTURE OF A COMPOSITION, A MONOCLONAL ANTIBODY, A METHOD FOR THEIR PREPARATION, A HYBRIDOMA CELL, A LINK AGENT OF THE BETA FORM, A METHOD FOR YOUR PREPA |
US10/304,630 US20030161836A1 (en) | 1998-11-04 | 2002-11-26 | Biological materials and methods useful in the diagnosis and treatment of diseases |
US11/140,416 US7875259B2 (en) | 1998-11-04 | 2005-05-27 | Biological materials and methods useful in the diagnosis and treatment of diseases |
US11/974,794 US20080241861A1 (en) | 1998-11-04 | 2007-10-16 | Biological materials and methods useful in the diagnosis and treatment of diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9906217.6A GB9906217D0 (en) | 1999-03-18 | 1999-03-18 | Biological materials and methods useful in the diagnosis and treatment of diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9906217D0 true GB9906217D0 (en) | 1999-05-12 |
Family
ID=10849861
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9906217.6A Ceased GB9906217D0 (en) | 1998-11-04 | 1999-03-18 | Biological materials and methods useful in the diagnosis and treatment of diseases |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB9906217D0 (en) |
-
1999
- 1999-03-18 GB GBGB9906217.6A patent/GB9906217D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9925804D0 (en) | Biological materials and method useful in the diagnosis and treatment of diseases | |
IL205242A0 (en) | Substituted oxazolidinones and their use in the field of blood coagulation | |
AU2001293553A1 (en) | Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment | |
IL160917A0 (en) | Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions | |
HUP0203367A3 (en) | Benzylidine-thiazolidinediones and analogues and their use in the treatment of diabetes | |
AU3683800A (en) | Device for the therapeutic and cosmetic photo-processing of biological tissues and method for using the same | |
AU2001270484A1 (en) | Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations | |
GB0019302D0 (en) | Biological materials and the use thereof for the treatment of disease | |
HUP0201997A3 (en) | Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications | |
IL160018A0 (en) | Isoxazolopyridinones and use thereof in the treatment of parkinson's disease | |
NO20020207D0 (en) | Biological materials and methods useful in the diagnosis and treatment of disease | |
AU2001253886A1 (en) | Methylxanthines in the diagnosis and treatment of autistic disorder | |
AU2003245858A8 (en) | Uses of ngal-binding substances in the diagnosis and treatment of cancer diseases | |
AU2001296477A1 (en) | Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas | |
GB9908059D0 (en) | Diagnosis and treatment of diseases | |
GB9917878D0 (en) | Biological materials and methods useful in the diagnosis and treatment of diseases | |
GB9906217D0 (en) | Biological materials and methods useful in the diagnosis and treatment of diseases | |
GB0205963D0 (en) | Biological materials and methods useful in the diagnosis and treatment of diseases | |
GB0113011D0 (en) | Biological materials and methods useful in the diagnosis and treatment of diseases | |
GB9824091D0 (en) | Biological materials and methods useful in the diagnosis and treatment of diseases | |
GB9917491D0 (en) | Biological materials and methods useful in the diagnosis and treastment of diseases | |
AUPQ223999A0 (en) | Intracellular feedback controls in the diagnosis and treatment of human disease | |
GB0029613D0 (en) | Biological materials and the use thereof in the treatment of disease | |
AU5875599A (en) | Polymorphisms in the human vcam-1 gene, suitable for diagnosis and treatment of vcam-1 ligand mediated diseases | |
AU5876399A (en) | Polymorphisms in the human beta1 integrin subunit gene, suitable for diagnosis and treatment of integrin ligand mediated diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |